Department of Neurosurgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; Department of Neurosurgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Department of Neurosurgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
World Neurosurg. 2024 May;185:e731-e740. doi: 10.1016/j.wneu.2024.02.120. Epub 2024 Feb 28.
Opening the oculomotor triangle (OT) and removing the posterior fossa lesion by endoscopic endonasal approach (EEA) is challenging for even an experienced endoscopic neurosurgeon. We summarize the treatment experience and technical nuances with EEA for resection of pituitary neuroendocrine tumors and cavernous sinus (CS) meningiomas invading through the OT.
Between 2018 and 2022, 8 patients, comprising 5 with pituitary neuroendocrine tumors (3 with nonfunctioning and 2 with somatotroph tumors with increased levels of growth hormone) and 3 CS meningiomas, were treated using an endoscopic endonasal transoculomotor triangle approach. The critical surgical technique is continuously opening the diaphragma sellae from medial to lateral toward the interclinoidal ligament and transecting it to enlarge the OT. We evaluated preoperative tumor size, previous surgical history, preoperative symptoms, extent of tumor resection, histopathology, and postoperative complications for all patients.
The gross total resection (defined as complete removal) in 3 patients (38%), near-total resection (defined as >95% removal) in 4 patients (50%), and subtotal resection (defined as ≤90% removal) in 1 patient (12%) and gross total resection of tumor invading through the OT was achieved in all patients through pure EEA. Two of 3 patients with visual deficits in nonfunctioning pituitary neuroendocrine tumors improved, and the other remained stable postoperatively. One patient showed transient oculomotor nerve palsy. The growth hormone level of the 2 patients with somatotroph tumors declined to normal. For 3 patients with CS meningiomas, cranial nerve palsy improved in 2 patients, whereas the other patient developed increased facial numbness after surgery.
The endoscopic endonasal transoculomotor triangle approach is an efficient surgical option for tumors with CS invasion and OT penetration.
即使对于经验丰富的内镜神经外科医生来说,通过内镜经鼻入路(EEA)打开动眼神经三角(OT)并切除后颅窝病变也是具有挑战性的。我们总结了通过 EEA 治疗经 OT 侵犯的垂体神经内分泌肿瘤和海绵窦(CS)脑膜瘤的治疗经验和技术要点。
2018 年至 2022 年,8 例患者(5 例垂体神经内分泌肿瘤,3 例无功能,2 例生长激素分泌性肿瘤)和 3 例 CS 脑膜瘤采用内镜经鼻经动眼神经三角入路治疗。关键手术技术是从内侧向外侧连续打开鞍隔并横断,以扩大 OT。我们评估了所有患者的术前肿瘤大小、既往手术史、术前症状、肿瘤切除程度、组织病理学和术后并发症。
3 例(38%)患者实现大体全切除(定义为完全切除),4 例(50%)患者实现近全切除(定义为>95%切除),1 例(12%)患者实现次全切除(定义为≤90%切除),所有患者均通过纯 EEA 实现了肿瘤的大体全切除,侵犯 OT。3 例无功能垂体神经内分泌肿瘤患者中,2 例视力减退患者改善,另 1 例术后保持稳定。1 例患者出现短暂动眼神经麻痹。2 例生长激素分泌性肿瘤患者的生长激素水平降至正常。对于 3 例 CS 脑膜瘤患者,2 例患者颅神经麻痹改善,而另 1 例患者术后出现面部麻木加重。
对于 CS 侵犯和 OT 穿透的肿瘤,内镜经鼻经动眼神经三角入路是一种有效的手术选择。